USA, ex. rel., Lauren Kieff, et al. v. Wyeth

  1. January 22, 2018

    Attorneys Squabble Over Cut Of $785M Pfizer FCA Deal

    Attorneys who were fired less than halfway into a whistleblower case against a Pfizer subsidiary went to trial Monday to bicker over who should get credit for resolving the False Claims Act lawsuit and $21 million in outstanding attorneys' fees that go with its $785 million settlement.

  2. May 10, 2017

    Pfizer Settles Fee Dispute In $785M FCA Deal

    Pfizer Inc. and a relator who blew the whistle on false claims have agreed to resolve their dispute over how much in attorneys' fees the company should pay after its $785 million settlement.

  3. November 29, 2016

    Whistleblower In $785M Pfizer FCA Deal Agrees To Fees Split

    A whistleblowing doctor who helped win a $785 million False Claims Act settlement with Pfizer Inc. agreed with his former lawyers Tuesday on a split of attorneys' fees, resolving one of several disputes about paying a battalion of attorneys.

  4. February 16, 2016

    Pfizer To Pay $785M To Settle FCA Claims Over Protonix

    Pfizer said Tuesday that it expects to pay $785 million to settle False Claims Act suits alleging its Wyeth unit overcharged Medicaid for heartburn drug Protonix, bringing a momentous end to whistleblower litigation over the program's discount requirements.

  5. November 13, 2015

    Wyeth Rejects Claim That It Promoted Off-Label Prescribing

    Pfizer's Wyeth Pharmaceuticals Inc. on Thursday told a Massachusetts federal court that a whistleblower can't prove the drugmaker encouraged physicians to prescribe its acid reflux drug off label, as part of a larger False Claims Act suit accusing the company of overcharging Medicare and Medicaid. 

  6. October 22, 2015

    Wyeth Should Face Drug Rebate Claims In Court, States Say

    Several states intervening in a whistleblower suit accusing Pfizer-owned Wyeth Pharmaceuticals of overcharging Medicaid by hundreds of millions of dollars for an acid reflux drug told a Massachusetts federal court Wednesday that federal law permits them to seek rebates through the federal courts instead of through administrative processes.

  7. September 14, 2015

    Wyeth Says Medicaid Didn't Trigger Protonix Discounts

    Wyeth Pharmaceuticals Inc. has asked a Massachusetts federal judge to dismiss a whistleblower suit claiming the Pfizer Inc.-owned drug company overcharged 16 state Medicaid programs by hundreds of millions of dollars for the acid reflux drug Protonix, arguing the purchase agreements didn't trigger a discount.

  8. September 02, 2015

    Mass. Judge Says Pfizer Whistleblower Suit Likely To Proceed

    The Massachusetts federal judge overseeing two consolidated whistleblower suits accusing the pharmaceutical arm of Pfizer Inc. of overcharging state Medicaid programs hundred of millions of dollars for the acid reflux drug Protonix said Tuesday he was inclined to deny the company's four-year-old motion for summary judgment.

  9. June 19, 2009

    States Join Qui Tam Medicaid Suits Against Wyeth

    Fifteen states have formally intervened in a pair of whistleblower lawsuits accusing Wyeth of making bundling arrangements under which it charged state Medicaid programs hundreds of millions of dollars more for acid reflux treatment Protonix than it charged other customers.